Antivirulence Properties of Probiotics in Combating Microbial Pathogenesis

Advances in Applied Microbiology

Volumn 98, Issue , 2017, Pages 1-29

  Surendran Nair, M ^a   Amalaradjou, M A ^a   Venkitanarayanan, K ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Antibiosis; Attenuation; Infections; Mode of action; Pathogens; Probiotics; Virulence

Indexed keywords

ANTITOXIN; EXOTOXIN; PROBIOTIC AGENT;

ANTIBIOSIS; ARTICLE; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIAL SECRETION SYSTEM; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BIOFILM; HOST; NONHUMAN; PATHOGENESIS; QUORUM SENSING; ANIMAL; DRUG THERAPY; GASTROINTESTINAL TRACT; HUMAN; INTESTINE; INTESTINE FLORA; LACTOBACILLACEAE; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY;

ANIMALS; DRUG THERAPY; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INTESTINES; LACTOBACILLACEAE; PROBIOTICS;

EID: 85011003485     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.aambs.2016.12.001     Document Type: Article

References (127)

1. Aldick, T., Bielaszewska, M., Uhlin, B.E., Humpf, H., Wai, S.N., Karch, H., Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin. Molecular Microbiology 71:6 (2009), 1496–1508.
2. Altenhoefer, A., Oswald, S., Sonnenborn, U., Enders, C., Schulze, J., Hacker, J., Oelschlaeger, T.A., The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunology and Medical Microbiology 40:3 (2004), 223–229.
3. Anderson, R.C., Cookson, A.L., McNabb, W.C., Park, Z., McCann, M.J., Kelly, W.J., Roy, N.C., Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiology, 10(1), 2010, 1.
4. Andrews, N.W., Portnoy, D.A., Cytolysins from intracellular pathogens. Trends in Microbiology 2:8 (1994), 261–263.
5. Antunes, L.C.M., Ferreira, R.B., Buckner, M.M., Finlay, B.B., Quorum sensing in bacterial virulence. Microbiology 156:8 (2010), 2271–2282.
6. Asahara, T., Shimizu, K., Nomoto, K., Hamabata, T., Ozawa, A., Takeda, Y., Probiotic bifidobacteria protect mice from lethal infection with shiga toxin-producing Escherichia coli O157:H7. Infection and Immunity 72:4 (2004), 2240–2247.
7. Belizário, J.E., Napolitano, M., Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Frontiers in Microbiology, 6, 2015.
8. Bermudez-Brito, M., Plaza-Diaz, J., Munoz-Quezada, S., Gomez-Llorente, C., Gil, A., Probiotic mechanisms of action. Annals of Nutrition and Metabolism 61:2 (2012), 160–174, 10.1159/000342079.
9. Bernet, M.F., Brassart, D., Neeser, J.R., Servin, A.L., Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35:4 (1994), 483–489.
10. Botes, M., Loos, B., van Reenen, C.A., Dicks, L.M., Adhesion of the probiotic strains Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 to caco-2 cells under conditions simulating the intestinal tract, and in the presence of antibiotics and anti-inflammatory medicaments. Archives of Microbiology 190:5 (2008), 573–584.
11. Bronner, S., Monteil, H., Prévost, G., Regulation of virulence determinants in Staphylococcus aureus: Complexity and applications. FEMS Microbiology Reviews 28:2 (2004), 183–200.
12. Carey, C.M., Kostrzynska, M., Ojha, S., Thompson, S., The effect of probiotics and organic acids on shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. Journal of Microbiological Methods 73:2 (2008), 125–132.
13. Casadevall, A., Feldmesser, M., Pirofski, L.A., Induced humoral immunity and vaccination against major human fungal pathogens. Current Opinion in Microbiology 5:4 (2002), 386–391.
14. Casadevall, A., Pirofski, L.A., Host-pathogen interactions: Redefining the basic concepts of virulence and pathogenicity. Infection and Immunity 67:8 (1999), 3703–3713.
15. Casadevall, A., Pirofski, L.A., Host-pathogen interactions: The attributes of virulence. The Journal of Infectious Diseases 184:3 (2001), 337–344 pii:JID010184.
16. Casadevall, A., Pirofski, L.A., Virulence factors and their mechanisms of action: The view from a damage–response framework. Journal of Water and Health 7:S1 (2009), S2–S18.
17. Castagliuolo, I., LaMont, J.T., Nikulasson, S.T., Pothoulakis, C., Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infection and Immunity 64:12 (1996), 5225–5232.
18. Center for Disease Control and Prevention Antibiotic Resistance Threats in the United States, Available at: http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf, 2013.
19. Chen, X., Kokkotou, E.G., Mustafa, N., Bhaskar, K.R., Sougioultzis, S., O'Brien, M., Kelly, C.P., Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. Journal of Biological Chemistry 281:34 (2006), 24449–24454.
20. Choi, C.H., Chang, S.K., Alteration of gut microbiota and efficacy of probiotics in functional constipation. Journal of Neurogastroenterology and Motility 21:1 (2015), 4–7, 10.5056/jnm14142.
21. Cleveland, J., Montville, T.J., Nes, I.F., Chikindas, M.L., Bacteriocins: Safe, natural antimicrobials for food preservation. International Journal of Food Microbiology 71:1 (2001), 1–20.
22. Collado, M.C., Grześkowiak, Ł., Salminen, S., Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa. Current Microbiology 55:3 (2007), 260–265.
23. Collado, M.C., Jalonen, L., Meriluoto, J., Salminen, S., Protection mechanism of probiotic combination against human pathogens: In vitro adhesion to human intestinal mucus. Asia Pacific Journal of Clinical Nutrition 15:4 (2006), 570–575.
24. Collin, F., Thompson, R.E., Jolliffe, K.A., Payne, R.J., Maxwell, A., Fragments of the bacterial toxin microcin B17 as gyrase poisons. PLoS One, 8(4), 2013, e61459.
25. Corr, S.C., Li, Y., Riedel, C.U., O'Toole, P.W., Hill, C., Gahan, C.G., Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proceedings of the National Academy of Sciences of the United States of America 104:18 (2007), 7617–7621.
26. Corsini, G., Karahanian, E., Tello, M., Fernandez, K., Rivero, D., Saavedra, J.M., Ferrer, A., Purification and characterization of the antimicrobial peptide microcin N. FEMS Microbiology Letters 312:2 (2010), 119–125.
27. Cotar, A.I., Chifiriuc, M.C., Dinu, S., Pelinescu, D., Banu, O., Lazãr, V., Quantitative real-time PCR study of the influence of probiotic culture soluble fraction on the expression of Pseudomonas aeruginosa quorum sensing genes. Romanian Archives of Microbiology and Immunology 69:4 (2010), 213–223.
28. Cvitkovitch, D.G., Li, Y.H., Ellen, R.P., Quorum sensing and biofilm formation in Streptococcal infections. The Journal of Clinical Investigation 112:11 (2003), 1626–1632.
29. Dautin, N., Bernstein, H.D., Protein secretion in gram-negative bacteria via the autotransporter pathway. Annual Review of Microbiology 61 (2007), 89–112.
30. Davidson, J.N., Hirsh, D.C., Bacterial competition as a means of preventing neonatal diarrhea in pigs. Infection and Immunity 13:6 (1976), 1773–1774.
31. Deriu, E., Liu, J.Z., Pezeshki, M., Edwards, R.A., Ochoa, R.J., Contreras, H., Raffatellu, M., Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host and Microbe 14:1 (2013), 26–37.
32. de Vrese, M., Stegelmann, A., Richter, B., Fenselau, S., Laue, C., Schrezenmeir, J., Probiotics–compensation for lactase insufficiency. The American Journal of Clinical Nutrition 73:2 Suppl. (2001), 421S–429S.
33. Dolan, R.M., Costerton, J.W., Biofilms: Survival mechanisms of clinically relevant microorganisms. Clinical Microbiology Reviews 15 (2002), 167–193.
34. Duquesne, S., Destoumieux-Garzón, D., Peduzzi, J., Rebuffat, S., Microcins, gene-encoded antibacterial peptides from enterobacteria. Natural Product Reports 24:4 (2007), 708–734.
35. Elli, M., Zink, R., Rytz, A., Reniero, R., Morelli, L., Iron requirement of lactobacillus spp. in completely chemically defined growth media. Journal of Applied Microbiology 88:4 (2000), 695–703.
36. Fair, R.J., Tor, Y., Antibiotics and bacterial resistance in the 21st century. Perspectives in Medicinal Chemistry, 6, 2014, 25.
37. FAO/WHO, Guidelines for the evaluation of probiotics in food. Food and agriculture organization of United Nations and world health organization, 2002, Working Group Report, London, Ontario.
38. Fernandes, C.F., Shahani, K.M., Amer, M.A., Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy products. FEMS Microbiology Reviews 3:3 (1987), 343–356.
39. Field, D., Begley, M., O'Connor, P.M., Daly, K.M., Hugenholtz, F., Cotter, P.D., Ross, R.P., Bioengineered Nisin A derivatives with enhanced activity against both gram positive and gram negative pathogens. PLoS One, 7(10), 2012, e46884.
40. Finlay, B.B., Falkow, S., Common themes in microbial pathogenicity revisited. Microbiology and Molecular Biology Reviews 61:2 (1997), 136–169.
41. Fioramonti, J., Theodorou, V., Bueno, L., Probiotics: What are they? What are their effects on gut physiology?. Best Practice and Research Clinical Gastroenterology 17:5 (2003), 711–724.
42. Flynn, S., van Sinderen, D., Thornton, G.M., Holo, H., Nes, I.F., Collins, J.K., Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118. Microbiology 148:4 (2002), 973–984.
43. Fujimura, K.E., Slusher, N.A., Cabana, M.D., Lynch, S.V., Role of the gut microbiota in defining human health. Expert Review of Anti-infective Therapy 8:4 (2010), 435–454.
44. Fuller, R., Probiotics in human medicine. Gut 32:4 (1991), 439–442.
45. Gale, C.A., Bendel, C.M., McClellan, M., Hauser, M., Becker, J.M., Berman, J., Hostetter, M.K., Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science 279:5355 (1998), 1355–1358.
46. Gauwerky, K., Borelli, C., Korting, H.C., Targeting virulence: A new paradigm for antifungals. Drug Discovery Today 14:3 (2009), 214–222.
47. Gill, H., Prasad, J., Probiotics, immunomodulation, and health benefits. Bioactive components of milk, 2008, Springer, New York, 423–454.
48. Gill, H.S., Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Practice and Research Clinical Gastroenterology 17:5 (2003), 755–773.
49. Gill, H.S., Rutherfurd, K.J., Cross, M.L., Gopal, P.K., Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. The American Journal of Clinical Nutrition 74:6 (2001), 833–839.
50. Gratz, S., Aflatoxin binding by probiotics: Experimental studies on intestinal aflatoxin transport, metabolism and toxicity. 2007, University of Kuopio.
51. Horn, D.L., Morrison, D.C., Opal, S.M., Silverstein, R., Visvanathan, K., Zabriskie, J.B., What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium. Clinical Infectious Diseases 31:4 (2000), 851–858 pii:CID990339.
52. Howarth, G.S., Wang, H., Role of endogenous microbiota, probiotics and their biological products in human health. Nutrients 5:1 (2013), 58–81.
53. Hoyer, L.L., The ALS gene family of Candida albicans. Trends in Microbiology 9:4 (2001), 176–180.
54. Hummel, S., Veltman, K., Cichon, C., Sonnenborn, U., Schmidt, M.A., Differential targeting of the E-Cadherin/beta-catenin complex by gram-positive probiotic lactobacilli improves epithelial barrier function. Applied and Environmental Microbiology 78:4 (2012), 1140–1147, 10.1128/AEM.06983-11.
55. Hussain, Z., Quigley, E., Systematic review: Complementary and alternative medicine in the irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 23:4 (2006), 465–471.
56. Ioana Cotar, A., Ionescu, B., Pelinescu, D., Voidarou, C., Lazar, V., Bezirtzoglou, E., Carmen Chifiriuc, M., Current solutions for the interception of quorum sensing in Staphylococcus aureus. Current Organic Chemistry 17:2 (2013), 97–104.
57. Ioana Cotar, A., Saviuc, C., Andreea Nita, R., Bezirtzoglou, E., Lazar, V., Carmen Chifiriuc, M., Anti-pathogenic strategies for fighting Pseudomonas aeruginosa infections-probiotic soluble compounds as inhibitors of quorum sensing genes expression. Current Organic Chemistry 17:2 (2013), 155–161.
58. Isolauri, E., Sutas, Y., Kankaanpaa, P., Arvilommi, H., Salminen, S., Probiotics: Effects on immunity. The American Journal of Clinical Nutrition 73:2 Suppl. (2001), 444S–450S.
59. Jay, J.M., Antimicrobial properties of diacetyl. Applied and Environmental Microbiology 44:3 (1982), 525–532.
60. Joerger, M.C., Klaenhammer, T.R., Cloning, expression, and nucleotide sequence of the Lactobacillus helveticus 481 gene encoding the bacteriocin helveticin J. Journal of Bacteriology 172:11 (1990), 6339–6347.
61. Khiralla, G.M., Mohamed, E.A., Farag, A.G., Elhariry, H., Antibiofilm effect of Lactobacillus pentosus and Lactobacillus plantarum cell-free supernatants against some bacterial pathogens. Journal of Biotech Research, 6, 2015, 86.
62. Kim, Y., Kim, S.H., Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7. Biochemical and Biophysical Research Communications 379:2 (2009), 324–329.
63. Kim, Y., Kim, S.H., Whang, K.Y., Kim, Y.J., Oh, S., Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. Journal of Microbiology and Biotechnology 18:7 (2008), 1278–1285 pii:7470.
64. Kirov, S.M., Castrisios, M., Shaw, J.G., Aeromonas flagella (polar and lateral) are enterocyte adhesins that contribute to biofilm formation on surfaces. Infection and Immunity 72:4 (2004), 1939–1945.
65. Klaenhammer, T.R., Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiology Reviews 12:1–3 (1993), 39–85.
66. Kozel, T.R., Murphy, W.J., Brandt, S., Blazar, B.R., Lovchik, J.A., Thorkildson, P., Lyons, C.R., mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia. Proceedings of the National Academy of Sciences of the United States of America 101:14 (2004), 5042–5047.
67. Krajmalnik-Brown, R., Ilhan, Z.E., Kang, D.W., DiBaise, J.K., Effects of gut microbes on nutrient absorption and energy regulation. Nutrition in Clinical Practice 27:2 (2012), 201–214.
68. Lievin, V., Peiffer, I., Hudault, S., Rochat, F., Brassart, D., Neeser, J.R., Servin, A.L., Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47:5 (2000), 646–652.
69. Liévin-Le Moal, V., Servin, A.L., The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: Mucins, antimicrobial peptides, and microbiota. Clinical Microbiology Reviews 19:2 (2006), 315–337.
70. Linhartova, I., Bumba, L., Masin, J., Basler, M., Osicka, R., Kamanova, J., Sebo, P., RTX proteins: A highly diverse family secreted by a common mechanism. FEMS Microbiology Reviews 34:6 (2010), 1076–1112, 10.1111/j.1574-6976.2010.00231.x.
71. Lyczak, J.B., Cannon, C.L., Pier, G.B., Establishment of Pseudomonas aeruginosa infection: Lessons from a versatile opportunist. Microbes and Infection 2:9 (2000), 1051–1060.
72. Macfarlane, G.T., Cummings, J.H., Probiotics and prebiotics: Can regulating the activities of intestinal bacteria benefit health?. The Western Journal of Medicine 171:3 (1999), 187–191.
73. Mack, D.R., Michail, S., Wei, S., McDougall, L., Hollingsworth, M.A., Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. The American Journal of Physiology 276:4 Pt 1 (1999), G941–G950.
74. Maloney, P.C., Microbes and membrane biology. FEMS Microbiology Reviews 7:1–2 (1990), 91–102.
75. Mattoo, S., Foreman-Wykert, A.K., Cotter, P.A., Miller, J.F., Mechanisms of Bordetella pathogenesis. Frontiers in Bioscience: A Journal and Virtual Library 6 (2001), E168–E186.
76. Medellin-Pena, M.J., Wang, H., Johnson, R., Anand, S., Griffiths, M.W., Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Applied and Environmental Microbiology 73:13 (2007), 4259–4267, 10.1128/AEM.00159-07.
77. Meindl, K., Schmiederer, T., Schneider, K., Reicke, A., Butz, D., Keller, S., Brönstrup, M., Labyrinthopeptins: A new class of carbacyclic lantibiotics. Angewandte Chemie International Edition 49:6 (2010), 1151–1154.
78. Mishra, C., Lambert, J., Production of anti-microbial substances by probiotics. Asia Pacific Journal of Clinical Nutrition 5 (1996), 20–24.
79. Moroni, O., Kheadr, E., Boutin, Y., Lacroix, C., Fliss, I., Inactivation of adhesion and invasion of food-borne Listeria monocytogenes by bacteriocin-producing Bifidobacterium strains of human origin. Applied and Environmental Microbiology 72:11 (2006), 6894–6901, 10.1128/AEM.00928-06.
80. Nau, R., Eiffert, H., Modulation of release of proinflammatory bacterial compounds by antibacterials: Potential impact on course of inflammation and outcome in sepsis and meningitis. Clinical Microbiology Reviews 15:1 (2002), 95–110.
81. Ohland, C.L., Macnaughton, W.K., Probiotic bacteria and intestinal epithelial barrier function. American Journal of Physiology. Gastrointestinal and Liver Physiology 298:6 (2010), G807–G819, 10.1152/ajpgi.00243.2009.
82. Oman, T.J., Boettcher, J.M., Wang, H., Okalibe, X.N., van der Donk, W.A., Sublancin is not a lantibiotic but an S-linked glycopeptide. Nature Chemical Biology 7:2 (2011), 78–80.
83. Parsek, M.R., Singh, P.K., Bacterial biofilms: An emerging link to disease pathogenesis. Annual Review of Microbiology 57:1 (2003), 677–701.
84. Pelto, L., Isolauri, E., Lilius, E.M., Nuutila, J., Salminen, S., Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clinical and Experimental Allergy 28:12 (1998), 1474–1479.
85. Peterson, J.W., Bacterial pathogenesis. Baron, S., (eds.) Medical microbiology, 4th ed., 1996, The University of Texas Medical Branch at Galveston, Galveston (TX) bookaccession:NBK8526.
86. Podbielski, A., Kreikemeyer, B., Cell density–dependent regulation: Basic principles and effects on the virulence of Gram-positive cocci. International Journal of Infectious Diseases 8:2 (2004), 81–95.
87. Pothoulakis, C., Kelly, C.P., Joshi, M.A., Gao, N., O'Keane, C.J., Castagliuolo, I., Lamont, J.T., Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology, 104, 1993, 1108.
88. Pratt, L.A., Kolter, R., Genetic analysis of Escherichia coli biofilm formation: Roles of flagella, motility, chemotaxis and type I pili. Molecular Microbiology 30:2 (1998), 285–293.
89. Pridmore, R.D., Pittet, A.C., Praplan, F., Cavadini, C., Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-salmonella activity. FEMS Microbiology Letters 283:2 (2008), 210–215, 10.1111/j.1574-6968.2008.01176.x.
90. Punyauppa-path, S., Phumkhachorn, P., Rattanachaikunsopon, P., Nisin: Production and mechanism of antimicrobial action. International Journal of Current Research and Review, 7(2), 2015, 47.
91. Rasko, D.A., Moreira, C.G., Li, D.R., Reading, N.C., Ritchie, J.M., Waldor, M.K., Hughes, D.T., Targeting QseC signaling and virulence for antibiotic development. Science 321:5892 (2008), 1078–1080.
92. Ray, K., Marteyn, B., Sansonetti, P.J., Tang, C.M., Life on the inside: The intracellular lifestyle of cytosolic bacteria. Nature Reviews Microbiology 7:5 (2009), 333–340.
93. Rebuffat, S., Microcins in action: Amazing defence strategies of enterobacteria. Biochemical Society Transactions 40:6 (2012), 1456–1462, 10.1042/BST20120183.
94. Rigothier, M., Maccario, J., Gayral, P., Inhibitory activity of saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro. Parasitology Research 80:1 (1994), 10–15.
95. Rintoul, M.R., de Arcuri, B.F., Salomon, R.A., Farias, R.N., Morero, R.D., The antibacterial action of microcin J25: Evidence for disruption of cytoplasmic membrane energization in Salmonella newport. FEMS Microbiology Letters 204:2 (2001), 265–270 pii: S0378109701004165.
96. Ripert, G., Racedo, S.M., Elie, A.M., Jacquot, C., Bressollier, P., Urdaci, M.C., Secreted compounds of the probiotic bacillus clausii strain O/C inhibit the cytotoxic effects induced by Clostridium difficile and Bacillus cereus toxins. Antimicrobial Agents and Chemotherapy 60:6 (2016), 3445–3454, 10.1128/AAC.02815-15.
97. Sable, S., Pons, A.M., Gendron-Gaillard, S., Cottenceau, G., Antibacterial activity evaluation of microcin J25 against diarrheagenic Escherichia coli. Applied and Environmental Microbiology 66:10 (2000), 4595–4597.
98. Sambanthamoorthy, K., Feng, X., Patel, R., Patel, S., Paranavitana, C., Antimicrobial and antibiofilm potential of biosurfactants isolated from lactobacilli against multi-drug-resistant pathogens. BMC Microbiology, 14(1), 2014, 1.
99. Schaechter, M., Desk encyclopedia of microbiology. 2010, Academic Press.
100. Schierack, P., Kleta, S., Tedin, K., Babila, J.T., Oswald, S., Oelschlaeger, T.A., Wieler, L.H., E. coli Nissle 1917 affects Salmonella adhesion to porcine intestinal epithelial cells. PLoS One, 6(2), 2011, e14712.
101. Shokouhfard, M., Kermanshahi, R.K., Shahandashti, R.V., Feizabadi, M.M., Teimourian, S., The inhibitory effect of a Lactobacillus acidophilus derived biosurfactant on biofilm producer serratia marcescens. Iranian Journal of Basic Medical Sciences, 18(10), 2015, 1001.
102. Sillanpää, J., Xu, Y., Nallapareddy, S.R., Murray, B.E., Höök, M., A family of putative MSCRAMMs from Enterococcus faecalis. Microbiology 150:7 (2004), 2069–2078.
103. Smith, R.S., Iglewski, B.H., P. aeruginosa quorum-sensing systems and virulence. Current Opinion in Microbiology 6:1 (2003), 56–60.
104. Sperandio, V., Mellies, J.L., Nguyen, W., Shin, S., Kaper, J.B., Quorum sensing controls expression of the type III secretion gene transcription and protein secretion in enterohemorrhagic and enteropathogenic Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 96:26 (1999), 15196–15201.
105. Staab, J.F., Bradway, S.D., Fidel, P.L., Sundstrom, P., Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283:5407 (1999), 1535–1538.
106. Teanpaisan, R., Piwat, S., Lactobacillus paracasei SD1, a novel probiotic, reduces mutans streptococci in human volunteers: A randomized placebo-controlled trial. Clinical Oral Investigations 18:3 (2014), 857–862.
107. Teanpaisan, R., Piwat, S., Dahlen, G., Inhibitory effect of oral Lactobacillus against oral pathogens. Letters in Applied Microbiology 53:4 (2011), 452–459.
108. Thomas, S.R., Elkinton, J.S., Pathogenicity and virulence. Journal of Invertebrate Pathology 85:3 (2004), 146–151.
109. Todoriki, K., Mukai, T., Sato, S., Toba, T., Inhibition of adhesion of food-borne pathogens to Caco-2 cells by Lactobacillus strains. Journal of Applied Microbiology 91:1 (2001), 154–159.
110. Trejo, F.M., Pérez, P.F., De Antoni, G.L., Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro. Antonie van Leeuwenhoek 98:1 (2010), 19–29.
111. Tulini, F.L., Lohans, C.T., Bordon, K.C., Zheng, J., Arantes, E.C., Vederas, J.C., De Martinis, E.C., Purification and characterization of antimicrobial peptides from fish isolate Carnobacterium maltaromaticum C2: Carnobacteriocin X and carnolysins A1 and A2. International Journal of Food Microbiology 173 (2014), 81–88.
112. Turner, P., Wu, Q., Piekkola, S., Gratz, S., Mykkänen, H., El-Nezami, H., Lactobacillus rhamnosus strain GG restores alkaline phosphatase activity in differentiating caco-2 cells dosed with the potent mycotoxin deoxynivalenol. Food and Chemical Toxicology 46:6 (2008), 2118–2123.
113. Valdés-Varela, L., Alonso-Guervos, M., García-Suárez, O., Gueimonde, M., Ruas-Madiedo, P., Screening of bifidobacteria and lactobacilli able to antagonize the cytotoxic effect of clostridium difficile upon intestinal epithelial HT29 monolayer. Frontiers in Microbiology, 7, 2016.
114. Vanaja, S.K., Russo, A.J., Behl, B., Banerjee, I., Yankova, M., Deshmukh, S.D., Rathinam, V.A., Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation. Cell 165:5 (2016), 1106–1119.
115. Van de Guchte, M., Ehrlich, S.D., Maguin, E., Production of growth-inhibiting factors by Lactobacillus delbrueckii. Journal of Applied Microbiology 91:1 (2001), 147–153.
116. Vassiliadis, G., Destoumieux-Garzón, D., Lombard, C., Rebuffat, S., Peduzzi, J., Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47. Antimicrobial Agents and Chemotherapy 54:1 (2010), 288–297.
117. Vuotto, C., Barbanti, F., Mastrantonio, P., Donelli, G., Lactobacillus brevis CD2 inhibits prevotella melaninogenica biofilm. Oral Diseases 20:7 (2014), 668–674.
118. Walsham, A.D., MacKenzie, D.A., Cook, V., Wemyss-Holden, S., Hews, C.L., Juge, N., Schüller, S., Lactobacillus reuteri inhibition of enteropathogenic Escherichia coli adherence to human intestinal epithelium. Frontiers in microbiology, 7, 2016.
119. Wann, E.R., Gurusiddappa, S., Höök, M., The Fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. Journal of Biological Chemistry 275:18 (2000), 13863–13871.
120. Warner, D.F., Mizrahi, V., The survival kit of Mycobacterium tuberculosis. Nature Medicine 13:3 (2007), 282–284.
121. WHO, http://www.who.int/mediacentre/factsheets/fs310/en/, 2014.
122. Wilson, J.W., Schurr, M.J., LeBlanc, C.L., Ramamurthy, R., Buchanan, K.L., Nickerson, C.A., Mechanisms of bacterial pathogenicity. Postgraduate Medical Journal 78:918 (2002), 216–224.
123. Wilson, K.H., Perini, F., Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infection and Immunity 56:10 (1988), 2610–2614.
124. Wu, H., Wang, A.H., Jennings, M.P., Discovery of virulence factors of pathogenic bacteria. Current Opinion in Chemical Biology 12:1 (2008), 93–101.
125. Yang, S., Lin, C., Sung, C.T., Fang, J., Antibacterial activities of bacteriocins: Application in foods and pharmaceuticals. Frontiers in Microbiology, 5, 2014, 241.
126. Yarwood, J.M., Schlievert, P.M., Quorum sensing in Staphylococcus infections. The Journal of Clinical Investigation 112:11 (2003), 1620–1625.
127. Zyrek, A.A., Cichon, C., Helms, S., Enders, C., Sonnenborn, U., Schmidt, M.A., Molecular mechanisms underlying the probiotic effects of Escherichia coli nissle 1917 involve ZO-2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair. Cellular Microbiology 9:3 (2007), 804–816.